Affiliation: New York University School of Medicine
- Predictors of antiretroviral medication adherence among a diverse cohort of adolescents with HIVSulachni Chandwani
Department of Pediatrics, New York University School of Medicine, New York, USA
J Adolesc Health 51:242-51. 2012..To compare prevalence and describe predictors of antiretroviral treatment adherence among adolescents with HIV acquired perinatally (PIY) or through risk behaviors (BIY)...
- A multimodal behavioral intervention to impact adherence and risk behavior among perinatally and behaviorally HIV-infected youth: description, delivery, and receptivity of adolescent impactSulachni Chandwani
New York University School of Medicine, New York 10016, USA
AIDS Educ Prev 23:222-35. 2011..Through use of multiple intervention modalities, Adolescent Impact was able to accommodate a diverse group of clinic-attending HIV-positive youth and address the need for a compact intervention for use in the clinical setting...
- Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225Sulachni Chandwani
Department of Pediatrics, New York University School of Medicine, New York City, NY 10016, USA
J Infect Dis 204:S179-89. 2011....
- Correlation between HIV-Specific CD8 cell production of interferon- gamma and plasma levels of HIV RNA in perinatally infected pediatric populationsWilliam Borkowsky
The Saul Krugman Division of Infectious Diseases, Division of Pediatrics, New York University School of Medicine, New York, New York 10016, USA
J Infect Dis 190:722-6. 2004..Attempts to establish the same correlation in small numbers of children have also been made, with similar controversy resulting...
- Characterizing social support: global and specific social support experiences of HIV-infected youthSusan Abramowitz
Department of Pediatrics, NYU School of Medicine, New York, New York 10016, USA
AIDS Patient Care STDS 23:323-30. 2009..Regular screening of HIV-positive youth for social support needs, especially BIY, and identification of sources for social support should be a regular part of care...
- Negative life events and depression in adolescents with HIV: a stress and coping analysisJennifer V Lewis
a Department of Pediatric Infectious Diseases, NYU Langone Medical Center, New York, NY, USA
AIDS Care 27:1265-74. 2015..Multimodal interventions that enhance social support and teach adaptive coping skills may help youth cope with environmental stresses and improve mental health outcomes...
- Natural history of HIV infected pediatric long-term or slow progressor population after the first decade of lifeJuliana A Ofori-Mante
Department of Pediatrics, Division of Infectious Diseases, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
Pediatr Infect Dis J 26:217-20. 2007..There is very limited information on this group of children beyond the first decade of life. A group of HIV-infected long-term nonprogressor/slow progressor children was studied...
- Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years oldMyron J Levin
Department of Pediatrics, University of Colorado Denver School of Medicine, Aurora, CO, USA
J Acquir Immune Defic Syndr 55:197-204. 2010..Quadrivalent human papillomavirus vaccine (QHPV) is > 95% effective in preventing infection with vaccine-type human papillomavirus. The safety and immunogenicity of QHPV are unknown in HIV-infected children...
- Immunoreconstitution in children receiving highly active antiretroviral therapy depends on the CD4 cell percentage at baselineDivna Nikolic-Djokic
New York University Medical Center, New York, NY 10016, USA
J Infect Dis 185:290-8. 2002..The results support the option of delaying HAART in early asymptomatic HIV-1 disease in children and the use of other markers of disease progression, in addition to virus load...
- A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicellaAnne A Gershon
Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
Pediatr Infect Dis J 28:653-5. 2009..There were no serious adverse events. Two years after vaccination 82% of subjects remained VZV-antibody positive and 60% had VZV-specific cell-mediated immunity. No child developed herpes zoster...